Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00717015 | Tamoxifen Pharmacokinetics and CYP2D6 Polymorphisms in Asian Women With Hormone Receptor Positive Breast Cancer | completed | — | — | National University Hospital, SingaporeOTHER | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00991978 | VEGF Early Imaging for Breast Cancer | completed | Early Phase 1 | 23 | University Medical Center GroningenOTHER | 1 | Mar 30, 2012 | clinicaltrials |
| NCT00020098 | Complementary or Alternative Medicine Practices Used by Women at Increased Risk for Breast Cancer | completed | N/A | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 29, 2012 | clinicaltrials |
| NCT00265655 | Satraplatin for Patients With Metastatic Breast Cancer (MBC) | completed | Phase 2 | 40 | AgennixINDUSTRY | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01048528 | Health SMART (Stress Management and Relaxation Training) | completed | Phase 2 | 33 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 27, 2012 | clinicaltrials |
| NCT01089049 | Effect of a Natural Health Product on Urinary Estrogen Metabolites | completed | Phase 1 / Phase 2 | 98 | Nutrasource Pharmaceutical and Nutraceutical Services, Inc.NETWORK | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00019812 | Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2 | completed | Phase 2 | 55 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00535184 | Test of Digital Breast Tomosynthesis vs. Common Mammography to Detect Breast Cancer for Women Undergoing Breast Biopsy | completed | — | 220 | GE HealthcareINDUSTRY | 0 | Mar 22, 2012 | clinicaltrials |
| NCT00149214 | Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens | completed | Phase 2 | 257 | Eli Lilly and CompanyINDUSTRY | 4 | Mar 21, 2012 | clinicaltrials |
| NCT00214162 | CHESS Caregivers Study: Web-based Support for Informal Caregivers in Cancer | completed | N/A | 235 | University of Wisconsin, MadisonOTHER | 1 | Mar 19, 2012 | clinicaltrials |
| NCT00454532 | A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 27 | BionovoINDUSTRY | 0 | Mar 16, 2012 | clinicaltrials |
| NCT00019019 | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas | completed | Phase 1 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT01399086 | Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer | completed | — | 140 | Hellenic Oncology Research GroupOTHER | 1 | Mar 13, 2012 | clinicaltrials |
| NCT00002585 | Pyrazoloacridine in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 20 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00054977 | Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors | completed | Phase 1 | 40 | Galectin Therapeutics Inc.INDUSTRY | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00800189 | Evaluation of the Informational Content of Setup Verification Images for Patients Receiving Breast Radiation Therapy (Anterior EPI)(Anterior EPI) | completed | N/A | 200 | British Columbia Cancer AgencyOTHER | 1 | Mar 9, 2012 | clinicaltrials |
| NCT00064311 | Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00080860 | Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer | completed | N/A | 60 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00301899 | Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab | completed | Phase 2 | 37 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00559039 | Effects of Fetal, Infant, and Early Childhood Exposures on Adult Cancer Risk in Women | completed | — | 128,700 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00233974 | Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery | completed | Phase 2 | 15 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 7, 2012 | clinicaltrials |
| NCT00432562 | A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer. | completed | Phase 1 | 31 | Mast Therapeutics, Inc.INDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00003392 | High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer | completed | Phase 2 | 61 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 22, 2012 | clinicaltrials |
| NCT00305448 | A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg(FINDER I) | completed | Phase 2 | 143 | AstraZenecaINDUSTRY | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00153218 | An Observational Study of Current Practice Pattern on the Treatment of Women With Metastatic Breast Cancer Whose Tumors Overexpress Her2neu | completed | — | 94 | Cancer Research NetworkOTHER | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00214864 | A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer | completed | Phase 2 | 18 | Cancer Research NetworkOTHER | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00336791 | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer | completed | Phase 3 | 273 | M.D. Anderson Cancer CenterOTHER | 4 | Feb 14, 2012 | clinicaltrials |
| NCT00936442 | Arimidex Therapy Compliance Electronic Monitoring System(ARTEMIS) | completed | — | 104 | AstraZenecaINDUSTRY | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00821613 | Data Collection Study of Raw Thermal Images for the Purpose of Developing a Device for Early Detection of Breast Cancer | completed | — | 1,827 | Real Imaging Ltd.INDUSTRY | 1 | Feb 8, 2012 | clinicaltrials |
| NCT00006108 | Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00156312 | Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine | completed | N/A | 25 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00291083 | Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer | completed | — | 229 | Carol Fabian, MDOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00900094 | UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer(IRB 2000-294) | completed | — | 200 | University of Michigan Rogel Cancer CenterOTHER | 0 | Feb 7, 2012 | clinicaltrials |
| NCT00973557 | The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function | completed | — | 6 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01108315 | Comprehensive Patient Reported Outcomes (PRO) Management for Oncology Practice | completed | Phase 1 / Phase 2 | 138 | BrightOutcomeINDUSTRY | 1 | Feb 6, 2012 | clinicaltrials |
| NCT00029224 | Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions | completed | Phase 4 | 500 | NovartisINDUSTRY | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00581724 | Pain in Cancer Survivors | completed | — | 200 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 26, 2012 | clinicaltrials |
| NCT00206466 | Biologic Correlative Taxotere/AC(TAX/AC) | completed | Phase 2 | 70 | Baylor Breast Care CenterOTHER | 1 | Jan 25, 2012 | clinicaltrials |
| NCT00776308 | Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who Are About to go to Surgery(MBI) | completed | — | 98 | Mayo ClinicOTHER | 1 | Jan 25, 2012 | clinicaltrials |
| NCT00943527 | Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast | completed | — | 110 | Mayo ClinicOTHER | 1 | Jan 25, 2012 | clinicaltrials |
| NCT00462410 | Effect of Advertisements on Treatment Compliance in Women With Breast Cancer | completed | N/A | 65 | Institut BergoniéOTHER | 0 | Jan 23, 2012 | clinicaltrials |
| NCT00897884 | Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer | completed | N/A | 39 | Mount Sinai Hospital, CanadaOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT00572598 | Pilot Study of 18F Fluoropaclitaxel (FPAC) | completed | Early Phase 1 | 6 | Virginia Commonwealth UniversityOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT01508546 | Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer | completed | Phase 3 | 565 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT00623233 | Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 52 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 9, 2012 | clinicaltrials |
| NCT00566085 | New Technique as an Additional Diagnostic Tool for Women Undergoing Neoadjuvant Therapy for Breast Cancer | completed | N/A | 20 | Mayo ClinicOTHER | 1 | Jan 6, 2012 | clinicaltrials |
| NCT00566280 | Molecular Breast Imaging in Patients With a History of Bloody Nipple Discharge | completed | N/A | 14 | Mayo ClinicOTHER | 1 | Jan 6, 2012 | clinicaltrials |
| NCT00566553 | The Effect of Grape Seed Extract on Estrogen Levels of Postmenopausal Women | completed | N/A | 39 | Mayo ClinicOTHER | 1 | Jan 6, 2012 | clinicaltrials |
| NCT00002646 | Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer | completed | Phase 3 | 1,500 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jan 5, 2012 | clinicaltrials |
| NCT00532857 | Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab(PGH) | completed | Phase 2 | 53 | Jungsil RoOTHER_GOV | 1 | Jan 4, 2012 | clinicaltrials |
Data updated 24 days agoSource updated Apr 3, 2012source: clinicaltrials